Trial intelligence / Profile preview

Diuretic Comparison Project

NCT02185417Phase 3Completed

Sponsor
VA Office of Research & Development
Start
Jun 2016
Primary completion
Oct 2022
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of chlorthalidone in hypertension (HTN), sponsored by VA Office of Research & Development. Started Jun 2016; status: completed.

02

Drugs

chlorthalidone
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02185417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02185417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call